Literature DB >> 29132813

Mismatch negativity: A simple and useful biomarker of N-methyl-d-aspartate receptor (NMDAR)-type glutamate dysfunction in schizophrenia.

Michael Avissar1, Daniel Javitt2.   

Abstract

Entities:  

Keywords:  Biomarker; Mismatch negativity; N-methyl-d-aspartate; NMDA; Schizophrenia

Mesh：

Substances：

Year:  2017        PMID： 29132813     DOI： 10.1016/j.schres.2017.11.006

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  10 in total

1.  The Thalamocortical Circuit of Auditory Mismatch Negativity.

Authors:  Peter Lakatos; Monica N O'Connell; Annamaria Barczak; Tammy McGinnis; Samuel Neymotin; Charles E Schroeder; John F Smiley; Daniel C Javitt
Journal:  Biol Psychiatry       Date:  2019-11-09       Impact factor: 13.382

Review 2.  Potential Roles of Redox Dysregulation in the Development of Schizophrenia.

Authors:  Diana O Perkins; Clark D Jeffries; Kim Q Do
Journal:  Biol Psychiatry       Date:  2020-04-02       Impact factor: 13.382

3.  Acute effects of Δ9-tetrahydrocannabinol and cannabidiol on auditory mismatch negativity.

Authors:  Lisa-Marie Greenwood; Samantha J Broyd; Hendrika H van Hell; Juanita Todd; Alison Jones; Robin M Murray; Rodney J Croft; Patricia T Michie; Nadia Solowij
Journal:  Psychopharmacology (Berl)       Date:  2021-11-01       Impact factor: 4.530

4.  Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders.

Authors:  Musa Basseer Sami; Sagnik Bhattacharyya
Journal:  J Psychopharmacol       Date:  2018-03-29       Impact factor: 4.153

5.  Deficits in Pre-attentive Processing of Spatial Location and Negative Symptoms in Subjects at Clinical High Risk for Schizophrenia.

Authors:  Pejman Sehatpour; Michael Avissar; Joshua T Kantrowitz; Cheryl M Corcoran; Heloise M De Baun; Gaurav H Patel; Ragy R Girgis; Gary Brucato; Javier Lopez-Calderon; Gail Silipo; Elisa Dias; Antigona Martinez; Daniel C Javitt
Journal:  Front Psychiatry       Date:  2021-02-02       Impact factor: 4.157

6.  Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signaling.

Authors:  Wei Chou Tseng; Veronica Reinhart; Thomas A Lanz; Mark L Weber; Jincheng Pang; Kevin Xuong Vinh Le; Robert D Bell; Patricio O'Donnell; Derek L Buhl
Journal:  Transl Psychiatry       Date:  2021-02-19       Impact factor: 6.222

7.  Decoding violated sensory expectations from the auditory cortex of anaesthetised mice: Hierarchical recurrent neural network depicts separate 'danger' and 'safety' units.

Authors:  Jamie A O'Reilly; Thanate Angsuwatanakul; Jordan Wehrman
Journal:  Eur J Neurosci       Date:  2022-06-22       Impact factor: 3.698

Review 8.  A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology.

Authors:  Daniel C Javitt; Steven J Siegel; Kevin M Spencer; Daniel H Mathalon; L Elliot Hong; Antigona Martinez; Cindy L Ehlers; Atheir I Abbas; Tobias Teichert; Peter Lakatos; Thilo Womelsdorf
Journal:  Neuropsychopharmacology       Date:  2020-05-06       Impact factor: 8.294

Review 9.  Early Intervention and a Direction of Novel Therapeutics for the Improvement of Functional Outcomes in Schizophrenia: A Selective Review.

Authors:  Masayoshi Kurachi; Tsutomu Takahashi; Tomiki Sumiyoshi; Takashi Uehara; Michio Suzuki
Journal:  Front Psychiatry       Date:  2018-02-19       Impact factor: 4.157

10.  Bimodal distribution of tone-matching deficits indicates discrete pathophysiological entities within the syndrome of schizophrenia.

Authors:  Clément Dondé; Antigona Martínez; Joshua T Kantrowitz; Gail Silipo; Elisa C Dias; Gaurav H Patel; Juan Sanchez-Peña; Cheryl M Corcoran; Alice Medalia; Alice Saperstein; Blair Vail; Daniel C Javitt
Journal:  Transl Psychiatry       Date:  2019-09-06       Impact factor: 6.222
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.